LTR's drug is approved in Aus but not USA.
I'd assume its a slam dunk for FDA approval opening up a market of close to 30 - 50 million people...
If LTR cant get it across the line, maybe thats where we can step in. Put in some cash to get it approved and take a % off the top of sales if they use our platform.
What we arent thinking about is that with each product opening up a new market, customers for other drugs will be exposed to other drugs on the platform. Which they can use word of mouth to friends and family and thus begins a Temu/Amazon sort of marketing snowball effect.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
30.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $588.2M | |||
| Open | High | Low | Value | Volume |
| 30.5¢ | 31.0¢ | 30.0¢ | $2.131M | 7.020M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 18 | 504695 | 30.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.5¢ | 38124 | 3 |
View Market Depth
| Last trade - 16.10pm 24/06/2025 (20 minute delay) ? |
| BOT (ASX) Chart |